{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:08:12Z","timestamp":1778465292905,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-933","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T14:02:23Z","timestamp":1418306543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is there a subgroup of long-term evolution among patients with advanced lung cancer?: Hints from the analysis of survival curves from cancer registry data"],"prefix":"10.1186","volume":"14","author":[{"given":"Lizet","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Lorenzo-Luaces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Viada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaima","family":"Galan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Crombet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustin","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"5112_CR1","first-page":"21","volume":"2","author":"A Lage","year":"1986","unstructured":"Lage A, Pascual MR, P\u00e9rez R: Estudios sobre el pron\u00f3stico del c\u00e1ncer mamario. An\u00e1lisis de las curvas de mortalidad y reca\u00edda en el c\u00e1ncer de mama. Rev Cub Oncol. 1986, 2: 21-29.","journal-title":"Rev Cub Oncol"},{"key":"5112_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2288-11-96","volume":"11","author":"TM Andersson","year":"2011","unstructured":"Andersson TM, Dickman PW, Eloranta S, Lambert PC: Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011, 11: 96-10.1186\/1471-2288-11-96.","journal-title":"BMC Med Res Methodol"},{"issue":"14","key":"5112_CR3","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1158\/1078-0432.CCR-11-2859","volume":"18","author":"M Othus","year":"2012","unstructured":"Othus M, Barlogie B, Leblanc ML, Crowley JJ: Cure models as a useful statistical tool for analyzing survival. Clin Cancer Res. 2012, 18 (14): 3731-3736. 10.1158\/1078-0432.CCR-11-2859.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"5112_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bjc.6601955","volume":"91","author":"CL Weston","year":"2004","unstructured":"Weston CL, Douglas C, Craft AW, Lewis IJ, Machin D: Establishing long-term survival and cure in young patients with Ewing's sarcoma. Br J Cancer. 2004, 91 (2): 225-232.","journal-title":"Br J Cancer"},{"issue":"16","key":"5112_CR5","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1200\/JCO.2012.46.6615","volume":"31","author":"YE Yilmaz","year":"2013","unstructured":"Yilmaz YE, Lawless JF, Andrulis IL, Bull SB: Insights from mixture cure modeling of molecular markers for prognosis in breast cancer. J Clin Oncol. 2013, 31 (16): 2047-2054. 10.1200\/JCO.2012.46.6615.","journal-title":"J Clin Oncol"},{"key":"5112_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.2517-6161.1949.tb00020.x","volume":"11","author":"JM Boag","year":"1949","unstructured":"Boag JM: Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc B. 1949, 11: 15-44.","journal-title":"J R Stat Soc B"},{"key":"5112_CR7","first-page":"299","volume":"2","author":"WC Chen","year":"1985","unstructured":"Chen WC, Hill BM, Greenhouse JB, Fayos JV: Bayesian analysis of survival curves for cancer patients following treatment. Bayesian Stat. 1985, 2: 299-328.","journal-title":"Bayesian Stat"},{"key":"5112_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1080\/01621459.1994.10476889","volume":"89","author":"RA Maller","year":"1994","unstructured":"Maller RA, Zhou S: Testing for sufficient follow-up and outliers in survival data. J Am Stat Assoc. 1994, 89: 1499-1506. 10.1080\/01621459.1994.10476889.","journal-title":"J Am Stat Assoc"},{"key":"5112_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M","volume":"18","author":"R Angelis","year":"1999","unstructured":"Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A: Mixture models for cancer survical analysis: aplication to population-based data with covariates. Stat Med. 1999, 18: 144-454.","journal-title":"Stat Med"},{"key":"5112_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10985-009-9126-4","volume":"15","author":"J Zhan","year":"2009","unstructured":"Zhan J, Peng Y: Accelerated hazards mixture cure model. Lifetime Data Anal. 2009, 15: 455-467. 10.1007\/s10985-009-9126-4.","journal-title":"Lifetime Data Anal"},{"key":"5112_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1081\/SAC-200068372","volume":"34","author":"JM Marin","year":"2005","unstructured":"Marin JM, Rodriguez-Bernal MT, Wiper MP: Using weibull mixture distributions to model heterogeneous survival data. Communicat Stat. 2005, 34: 673-684.","journal-title":"Communicat Stat"},{"issue":"11","key":"5112_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/sim.1774","volume":"23","author":"B Yu","year":"2004","unstructured":"Yu B, Tiwari RC, Cronin KA, Feuer EJ: Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med. 2004, 23 (11): 1733-1747. 10.1002\/sim.1774.","journal-title":"Stat Med"},{"issue":"3","key":"5112_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/biostatistics\/kxl030","volume":"8","author":"PC Lambert","year":"2007","unstructured":"Lambert PC, Thompson JR, Weston CL, Dickman PW: Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007, 8 (3): 576-594. 10.1093\/biostatistics\/kxl030.","journal-title":"Biostatistics"},{"issue":"3","key":"5112_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.37757\/MR2009V11.N3.6","volume":"11","author":"Y Galan","year":"2009","unstructured":"Galan Y, Fernandez L, Torres P, Garcia M: Trends in Cuba's Cancer Incidence (1990 to 2003) and mortality (1990 to 2007). MEDICC Rev. 2009, 11 (3): 19-26.","journal-title":"MEDICC Rev"},{"issue":"5","key":"5112_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/03610920903480890","volume":"40","author":"M Nagode","year":"2011","unstructured":"Nagode M, Fajdiga M: The REBMIX algorithm for the univariate finite mixture estimation. Communicat Stat. 2011, 40 (5): 876-892.","journal-title":"Communicat Stat"},{"issue":"1","key":"5112_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1006\/jmps.1999.1278","volume":"44","author":"L Wasserman","year":"2000","unstructured":"Wasserman L: Bayesian model selection and model averaging. J Math Psychol. 2000, 44 (1): 92-107. 10.1006\/jmps.1999.1278.","journal-title":"J Math Psychol"},{"issue":"31","key":"5112_CR17","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2011.41.3799","volume":"30","author":"AM Eggermont","year":"2012","unstructured":"Eggermont AM, Suciu S, Testori A, Santinami M, Kruit WH, Marsden J, Punt CJ, Sales F, Dummer R, Robert C, Schadendorf D, Patel PM, de Schaetzen G, Spatz A, Keilholz U: Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol. 2012, 30 (31): 3810-3818. 10.1200\/JCO.2011.41.3799.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5112_CR18","doi-asserted-by":"publisher","first-page":"e1000281","DOI":"10.1371\/journal.pmed.1000281","volume":"7","author":"S Ambs","year":"2010","unstructured":"Ambs S: Prognostic significance of subtype classification for short- and long-term survival in breast cancer: survival time holds the key. PLoS Med. 2010, 7 (5): e1000281-10.1371\/journal.pmed.1000281.","journal-title":"PLoS Med"},{"issue":"27","key":"5112_CR19","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1002\/sim.3696","volume":"28","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Lee AH, Yau KK, Burke V, McLachlan GJ: A score test for assessing the cured proportion in the long-term survivor mixture model. Stat Med. 2009, 28 (27): 3454-3466. 10.1002\/sim.3696.","journal-title":"Stat Med"},{"key":"5112_CR20","first-page":"10","volume":"5","author":"B Yu","year":"2007","unstructured":"Yu B, Tiwari RC: Application of EM algorithm to mixture cure model for grouped relative survival data. J Data Sci. 2007, 5: 10-","journal-title":"J Data Sci"},{"key":"5112_CR21","doi-asserted-by":"publisher","first-page":"A398","DOI":"10.1016\/j.jval.2013.08.435","volume":"16","author":"L McCullagh","year":"2013","unstructured":"McCullagh L, Barry M: Survival analysis used in company submissions to the national centre for pharmacoeconomics. Ireland Value Health. 2013, 16: A398-","journal-title":"Ireland Value Health"},{"issue":"6","key":"5112_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.canep.2012.06.011","volume":"36","author":"LG Shack","year":"2012","unstructured":"Shack LG, Shah A, Lambert PC, Rachet B: Cure by age and stage at diagnosis for colorectal cancer patients in North West England, 1997\u20132004: a population-based study. Cancer Epidemiol. 2012, 36 (6): 548-553. 10.1016\/j.canep.2012.06.011.","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"5112_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2471\/BLT.07.046979","volume":"86","author":"R Swaminathan","year":"2008","unstructured":"Swaminathan R, Rama R, Shanta V: Lack of active follow-up of cancer patients in Chennai, India: implications for population-based survival estimates. Bull World Health Organ. 2008, 86 (7): 509-515. 10.2471\/BLT.07.046979.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"5112_CR24","first-page":"831","volume":"11","author":"M Dhar","year":"2010","unstructured":"Dhar M, Rao S, Vijaysimha R: Population based studies of cancer survival: scope for the developing countries. Asian Pac J Cancer Prev. 2010, 11 (3): 831-838.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"5112_CR25","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/cncr.24871","volume":"116","author":"T Wang","year":"2010","unstructured":"Wang T, Nelson RA, Bogardus A, Grannis FW: Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?. Cancer. 2010, 116 (6): 1518-1525. 10.1002\/cncr.24871.","journal-title":"Cancer"},{"issue":"4","key":"5112_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4103\/0019-509X.92248","volume":"48","author":"N Ahbeddou","year":"2011","unstructured":"Ahbeddou N, Fetohi M, Boutayeb S, Errihani H: Which non-small-cell lung cancer patients achieve long-term survival?. Indian J Cancer. 2011, 48 (4): 514-515. 10.4103\/0019-509X.92248.","journal-title":"Indian J Cancer"},{"issue":"6","key":"5112_CR27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/etm.2012.714","volume":"4","author":"S Ozkaya","year":"2012","unstructured":"Ozkaya S, Findik S, Dirican A, Atici AG: Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine. Exp Therap Med. 2012, 4 (6): 1035-1038.","journal-title":"Exp Therap Med"},{"issue":"1","key":"5112_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1440-1843.2011.02070.x","volume":"17","author":"E Giroux Leprieur","year":"2012","unstructured":"Giroux Leprieur E, Lavole A, Ruppert AM, Gounant V, Wislez M, Cadranel J, Milleron B: Factors associated with long-term survival of patients with advanced non-small cell lung cancer. Respirology. 2012, 17 (1): 134-142. 10.1111\/j.1440-1843.2011.02070.x.","journal-title":"Respirology"},{"key":"5112_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ni0208-109","volume":"9","author":"A Lage","year":"2008","unstructured":"Lage A: Connecting immunology research to public health: Cuban biotechnology. Nat Immunol. 2008, 9: 109-112. 10.1038\/ni0208-109.","journal-title":"Nat Immunol"},{"issue":"3","key":"5112_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.37757\/MR2009V11.N3.3","volume":"11","author":"A Lage","year":"2009","unstructured":"Lage A: Transforming cancer indicators begs bold new strategies from biotechnology. MEDICC Rev. 2009, 11 (3): 8-12.","journal-title":"MEDICC Rev"},{"issue":"13","key":"5112_CR31","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1158\/1078-0432.CCR-07-0588","volume":"13","author":"J Schlom","year":"2007","unstructured":"Schlom J, Arlen PM, Gulley JL: Cancer vaccines: moving beyond current paradigms. Clin Cancer Res. 2007, 13 (13): 3776-3782. 10.1158\/1078-0432.CCR-07-0588.","journal-title":"Clin Cancer Res"},{"key":"5112_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2051-1426-1-1","volume":"1","author":"TT Chen","year":"2013","unstructured":"Chen TT: Statistical issues and challenges in immunooncology. J Immuno Ther Cancer. 2013, 1: 1-9. 10.1186\/2051-1426-1-1.","journal-title":"J Immuno Ther Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-933\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T20:10:31Z","timestamp":1717618231000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-933","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"933"}}